Capitala Group has invested in Novellum Longevity, a company focused on managing wellness clinics, to capitalize on the growing demand for preventative healthcare solutions.
Target Company Overview
Capitala Group, a prominent private markets investment firm, has made a significant senior debt and equity co-investment in Novellum Longevity, a management services organization dedicated to the operation of longevity and functional wellness clinics across the United States. The company was established through the acquisition of the non-clinical assets of ThriveMD, PC, which is based in Denver and has another location in Vail, Colorado. Novellum aims to enhance access to advanced preventative care and health optimization services, such as hormone replacement therapy, peptide therapy, diagnostic labs, and regenerative medicine.
By focusing on a concierge-style approach, Novellum provides high-quality, science-backed aging care. This strategy not only addresses the root causes of health concerns but also enhances overall performance through a relationship-driven model. Such services position Novellum as a leader in a growing sector catering to wellness and longevity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The longevity and wellness industry has been increasingly prominent in the United States as consumer interest in preventative healthcare grows. The aging population is seeking more personalized and effective approaches to health managemen
Similar Deals
CPF Living Communities → Rivertown Ridge
2025
Revere Medical → CareMax, Inc.
2024
Turnspire Capital Partners → Pharmachem Innovations
2024
Praesidian Capital → Biologos Holdings, LLC
2024
CUC Inc. → Beyond Podiatry
2024
Safeguard DX Limited → Safeguard Biosystems Holdings Limited
2024
Capitala Group
invested in
Novellum Longevity
in 2025
in a Management Buyout / Buy-In (MBO) deal